Clinical trial
BWI202405: Assessment of Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the VARIPULSE™ Catheter System
NCT07227532 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BWI202405: Assessment of Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the VARIPULSE™ Catheter System
- Lead sponsor
- Biosense Webster, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 21, 2025
- Completion date
- December 31, 2030
- Enrollment
- 276 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.